Shiraki Masataka | Research Institute And Practice For Involutional Disease

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
Association of a Sequence Variation in the Gene Encoding Adiponectin Receptor 1 (ADIPOR1) with Body Mass Index in the Japanese Population
Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women
Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women
Diagnostic criteria for primary osteoporosis: year 2000 revision
Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure
Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
Association of Bone Metabolism Regulatory Factor Gene Polymorphisms With Susceptibility to Ossification of the Posterior Longitudinal Ligament of the Spine and Its Severity
Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy
Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
Validation of the Japanese Osteoporosis Quality of Life Questionnaire
Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
Effects of phosphorus-containing calcium preparation (bone meal powder) and calcium carbonate on serum calcium and phosphorus in young and old healthy volunteers: a double-blinded crossover study
Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis : a randomized prospective study
A polymorphic variant at the Werner helicase(WRN)gene is associated with bone density, but not spondylosis, in postmenopausal women
High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
Effect of 1α-Hydroxyvitamin D_3 on Loss of Bone Mineral Density Immediately after Artificial Menopause
ASSOCIATION OF ESTROGEN RECEPTOR DINUCLEOTIDE REPEAT POLYMORPHISM WITH OSTEOPOROSIS
Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D_3 load in Japanese subjects
Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
Effect of disuse on bone mineral content, lean mass, and fat mass in osteoarthritic patients
Bone and Calcium Metabolism in Werner's Syndrome
Breast arterial calcification and hypertension associated with vertebral fracture
Three years of treatment with minodronate in patients with postmenopausal osteoporosis
Diagnostic criteria for primary osteoporosis : year 2012 revision
Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis
Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol

もっと見る

スポンサーリンク